Results 211 to 220 of about 39,896 (258)

Functional/dissociative seizures as a manifestation of forced normalization in eyelid myoclonia with absence epilepsy

Epileptic Disorders, EarlyView.
Fernando Vasquez‐Lopez, Jimena Gonzalez‐Salido, Salvador Martínez‐Medina, Irving Fuentes‐Calvo, Diego A. Barrios‐González, Betsy C. Vázquez‐Cruz, Juan Carlos Vera‐López, Jimena Colado‐Martinez, Orelli Ruiz‐Rodríguez, Pilar Robles‐Lomelin, Maximiliano Salgado Deza, Diego A. Hernandez, Álvaro José Moreno Avellán, Mario A. Sebastián Díaz, Daniel Crail‐Meléndez, Ángel Ruiz‐Chow, Iris E. Martínez‐Juárez   +16 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The ‘Dalhousie Serotonin cocktail’ for treatment-resistant major depressive disorder

Journal of Psychopharmacology, 2001
We describe the successful treatment of five patients with treatment-resistant major depressive disorder (TR-MDD) with a combination pharmacotherapy of pindolol, tryptophan and nefazodone. Five TR-MDD outpatients who had previously not responded to at least four different antidepressant medication trials were initiated on 300 mg/day of nefazodone, 7.5 ...
Serdar Dursun, Stanley Kutcher, S Devarajan   +2 more
exaly   +3 more sources

Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder

Journal of Psychiatric Research, 2011
Treatment-resistant major depressive disorder (MDD) is a complex condition, with very low remission rates. Physical exercise has been used, with some encouraging results, as an alternative therapy in other depressive disorders. This study assessed the impact on depression and functioning parameters of a moderate intensity exercise program, as an ...
Ribeiro J, Jorge Mota-Pereira, Serafim Carvalho   +2 more
exaly   +4 more sources

Brexpiprazole for treatment-resistant major depressive disorder

Expert Opinion on Pharmacotherapy, 2019
Introduction:Treatment-resistant depression (TRD), seldom interchangeably referred to as 'depression inadequately responding to the standard antidepressant drug,' carries a significant burden. The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary ...
Fornaro M., Fusco A., Anastasia A., Cattaneo C. I., De Berardis D.   +4 more
openaire   +3 more sources

Axis III disorders in treatment-resistant major depressive disorder

Psychiatry Research, 2003
A number of naturalistic studies have found that medical co-morbidity conveys a worse long-term prognosis in the treatment of major depressive disorder (MDD). The purpose of this study was to test whether the presence of co-morbid medical conditions can predict clinical response in patients with treatment-resistant MDD (TRD) treated with open-label ...
George I, Papakostas, Timothy, Petersen, Dan V, Iosifescu, Pamela A, Roffi, Jonathan E, Alpert, Jerrold F, Rosenbaum, Maurizio, Fava, Andrew A, Nierenberg   +7 more
openaire   +2 more sources

The bipolar diathesis of treatment-resistant major depressive disorder

International Journal of Psychiatry in Clinical Practice, 2008
Objective. In this study, we determined the prevalence of bipolarity in patients with treatment-resistant depression (TRD) by investigating demographic and clinical characteristics, diagnostic subtypes and illness outcome of patients with resistant depression. Methods.
Young Sup, Woo, Jeong-Ho, Chae, Tae-Youn, Jun, Kwang-Soo, Kim, Won-Myong, Bahk   +4 more
openaire   +2 more sources

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Annals of Pharmacotherapy, 2012
OBJECTIVE: To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES: A MEDLINE search (1966-September 2011) was performed using the terms
Jordan R, Covvey, Alexis Noble, Crawford, Denise K, Lowe   +2 more
openaire   +2 more sources